The chemotherapy drugs and hormonal drugs in the biologics for the treatment of breast cancer included cyclosporine, penta flurfluralin, methylethalin, chemotherapy, taxol, and chemotherapy. The use of these drugs needed to be carried out under the guidance of doctors. In addition, Roche's breast cancer anti-HEL2 subterranean biological agent Herceptin (common name: trastuzhu injection (subterranean injection)) was the world's first innovative targeted drug against HEL2 breast cancer, and also the cornerstone of the treatment of HEL2-positive breast cancer. The new trastuzhu subterranean injection dosage form had reformed the treatment mode of HEL2-positive breast cancer. In recent years, innovative drugs such as Pajette and Hercella were approved for sale in China, which also helped in the treatment of breast cancer. Read more exciting novels for free
The commonly used drugs for chemotherapy for breast cancer relapse were as follows: 1. [Anthracyclines, such as doxorubin, epirubin, etc.] 2. taxus species, such as doethel, taxol, etc.; 3. Toxic drugs, such as capecitobin, cis-platinum, carbo platinum, etc.; 4. Xeloda (capecitobin) was also recommended for chemotherapy after relapse. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
There were mainly the following types of breast cancer anti-cancer drugs: 1. * * 2. ** Chemotherapy drugs **: including cyclocyclosporine, epirubin, taxol, taxol for injection, chemotherapy, capecitobin, doxorubicilin, pyrandoxorubicilin, pentflurfluralin, and S-1. 3. ** Target drugs **: For intravenous use, there are trastuzan and pertuzan. For oral use, there are pirotini and lapatini, as well as reboxili and DS - 8201 (detrastuzan). If the patient is positive for the Epidermal Growth factor receptor 2 gene, trastuzan (Herceptin) can be used in combination with chemotherapy. 4. ** Immune therapy drug **: Anti-PD-1/PD-L1 monoclonals. They are both targeted drugs (with a target) and immune drugs (mechanism). <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
The patent for the original palbocicril in China expired on January 10, 2023. It was a breast cancer treatment drug. In addition, the world's best-selling drug, Humira, had indications that included areas related to breast cancer (such as moderate to severe active rheumatism and other diseases. Although it was not directly indicated as a breast cancer treatment drug, the related diseases may be related to breast cancer). It was also a drug with a patent expired in the past decade, but it was not clear whether its patent expired was specifically related to breast cancer. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
In the treatment of breast cancer, some drugs can be used to enhance immunity. For example, non-specific active immune therapy drugs include bcg, thymosin, and ifon. In addition, immune checkpoint suppressors can fight breast cancer by activating the immune system. Common immune therapy drugs include pabolizumab, atezulizumab, etc. However, these drugs may cause adverse reactions such as cardiac toxicity and leukemia. Patients need to take them under the guidance of a doctor. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Domestically-produced breast cancer chemotherapy drugs such as pirotinib had strong efficacy, and clinical data crushed the imported drug lapatini. There were also taxol, trastuzumab, chemotherapy, etc. Among them, Utedron was the first and only approved epothilone anti-tumor drug in China. It was used for the treatment of relapsed and metastasized advanced breast cancer, breaking the long-term situation of no breakthrough chemotherapy drugs other than taxol in the treatment of advanced breast cancer in China. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
There were mainly the following types of breast cancer targeted drugs: 1. Anti-neoplastic targeted drugs: There are intravenous preparations and oral drugs, but the effect in the treatment of breast cancer is not ideal. For example, bevacidol (Avastin) will be considered in some cases. 2. Anti-Her- 2 targeted drugs: targeted at HER - 2 positive patients, it is the most important targeted drug for breast cancer, mainly including trastuzumab (Herceptin), pertubizab, dm- 1, lapatini, etc. The prerequisite for use was that the patient was positive for HER - 2 (+++ in the immune tissue test). If the immune tissue test was ++, the patient would need to undergo a further FISH test. The patient could only be used if the FISH test was positive. If the immune tissue test was + or-, the patient could not be used. 3. A targeted drug for patients with fetal mutations in the Brca lineage: The main drug is olaparib, which is used to treat patients with metastasizing breast cancer who have harmful or suspected harmful mutations in the Brca lineage and who are negative for the human embryonic growth factor receptor 2 (HEL2). 4. Immune therapy (in a sense, it was also a targeted drug): Anti-PD- 1/PD-L1 Monoclone Antibodies, which essentially relieved immune suppression and activated immune cells to kill cancer cells. 5. mTO inhibition drugs, such as everolimus and sirolimus, can inhibit the activation of the mTO signaling pathway, thereby suppressing the growth and metabolism of tumor cells. 6. Other targeted therapy drugs, such as Parp inhibition drugs, CD 4/6 inhibition drugs, etc. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
The drugs for early breast cancer include the following categories: 1. Hormonal receptor regulator, such as tamoxifen, toremifen, can be used in breast cancer patients with hormone receptor-positive before and after menstruation. 2. Aromatase inhibition drugs, such as letrozuo, anastrozuo, and eximestane, were mainly used in post-menstrual patients. They could also be used in combination with belly acupuncture before menstruation. 3. Ovary function suppressors (commonly known as belly needles): Representative drugs include goserelin and leuprorelin, which are suitable for breast cancer patients with premenstrual hormone receptor-positive. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
The liver-protecting drugs used for early chemotherapy of breast cancer included liver-protecting tablets, Glutathion tablets, Compound Ammine Glycerate injection, Diammine Glycerate Enteric capsules, Dicyclol tablets, and Yishanfu Polyene Phospholipidoline capsules. These drugs needed to be used under the guidance of a doctor. For example, liver-protecting tablets could protect the liver; Glutathione-based tablets could repair stem cells and detoxify; and compound licorice injection could protect the liver and improve the pain symptoms caused by liver damage. The bicyclol tablets had a good effect on reducing the index of Gu and C, but the effect on the index of Gu and Cao was not ideal. The Yishanfu Duoene Phospholidylcholin capsules did not improve the high index of transferment in some patients. Regarding the kidney protection drugs for early chemotherapy of breast cancer, the reference materials did not explicitly mention the relevant drugs. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
For cases of breast cancer with high hormone levels (usually referred to as oestrogen-receptor positive), the following are some of the drugs that may be used: 1. ** Hormonal receptor regulator **: - Tamoxifen and toremifen can be used in breast cancer patients with hormone receptor-positive before and after the menopause, but side effects such as night sweats, insomnia, and decreased libido may occur. The uterus and ovaries also need to be monitored. 2. Aromatase Inhibition: - Letrozuo, anastrozuo, and eximestane were mainly used for post-menstrual patients. For pre-menstrual patients, they could also be used in combination with belly acupuncture. There was no difference in the efficacy of the three drugs, but the side effects were slightly different. 3. ** Estrogen receptor down-regulator **: - Fulvestrant was used in patients with late-stage hormone receptor-positive breast cancer. It might have some effect on the digestive tract and liver function. 4. ** Ovary function suppressors (commonly known as belly needles)**: - Goserelin and leuprorelin could cause side effects such as hyperhidrosis, insomnia, and decreased libido in breast cancer patients with premenstrual hormone receptor-positive symptoms. They also had a certain impact on bone density. In addition, in the early years, there were cases of oral administration of carmoxifen to resist estrogens. When using these drugs for hormone therapy, it was necessary to closely observe the patient's reaction and side effects, such as breast pain, dry vaginas, etc., and timely adjust the dosage and plan according to the patient's condition. At the same time, it was necessary to evaluate the efficacy through regular examinations and tests. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
The anti-inflammatory drugs that breast cancer patients can take according to the doctor's advice are Ceftriaxone, Doxicyclin, Amoxilin, Clindamylin, Levofroxaxin, etc. These drugs had different mechanisms of action and precautions. For example, Ceftriaxone could be used to treat mastiff caused by bacteria infection, which required a skin test and monitoring of kidney function before use. Doxyclidine was suitable for breast abscesses caused by a variety of Gram positive and negative bacteria, and should be avoided from strong sunlight when taking it. Aoxicilin was effective for mastiff caused by sensitive strains, and attention should be paid to allergic reactions when taking it. Clindamylin was suitable for mastectomy caused by drug-resistant Staph. Aureus, and the infusion speed should be controlled during intravenous injection. Levofloaxin was suitable for mastectomy caused by sensitive strains, and was prohibited in women who were nursing. Because breast cancer is a serious disease, it is recommended that patients use drugs under the guidance of a doctor to reduce the risk of adverse reactions and drug interactions. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>